It is a agriculture private limited company based in Mumbai, Maharashtra, India, established in 2015.
2015 | Mumbai, Maharashtra, India | ActiveSanguine Novaseeds Private Limited, a active private limited company, was established on 08 January 2015 in Mumbai, Maharashtra, India. Engaging in seed production & distribution within the professional, scientific and technical sector, it holds CIN: U01112MH2015PTC260765. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.20 Cr and a paid-up capital of ₹1.85 Cr.
It upholds a compliant status. Its leadership includes Sandra Rajnikant Shroff (Additional Director), Rajnikant Devidas Shroff (Director), Shilpa Pradeep Sagar (Additional Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Kanta Niwas, Ground Floor, 11Th Road, Opp. Madhu Park , Khar (West), Mumbai, Maharashtra, 400052.
U01112MH2015PTC260765
260765
08 January 2015
₹10.20 Cr
₹1.85 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sanguine Novaseeds Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sandra Rajnikant Shroff | Additional Director | 30 Oct 2024 | Current |
| Rajnikant Devidas Shroff | Director | 08 Jan 2015 | Current |
| Shilpa Pradeep Sagar | Additional Director | 30 Oct 2024 | Current |
| Arun Chandrasen Ashar | Director | 08 Jan 2015 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sanguine Novaseeds Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 166% increase. The company also saw a substantial fall in profitability, with a 4949.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 74.71%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Sanguine Novaseeds had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sanguine Novaseeds, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sanguine Novaseeds, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanguine Novaseeds's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sandra Rajnikant Shroff was appointed as a Additional Director was appointed as a Additional Director on 30 Oct 2024 & has been associated with this company since 1 year 1 month . was documented.
The activity Shilpa Pradeep Sagar was appointed as a Additional Director was appointed as a Additional Director on 30 Oct 2024 & has been associated with this company since 1 year 1 month . was completed.
The activity Sanguine Novaseeds Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Sanguine Novaseeds Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on Rajnikant Devidas Shroff was appointed as a Director was appointed as a Director on 08 Jan 2015 & has been associated with this company since 10 years 10 months . was documented.
The activity Arun Chandrasen Ashar was appointed as a Director was appointed as a Director on 08 Jan 2015 & has been associated with this company since 10 years 10 months . was completed.
The CIN of Sanguine Novaseeds Private Limited is U01112MH2015PTC260765.
Sanguine Novaseeds Private Limited is headquartered at Kanta Niwas, Ground Floor, 11Th Road, Opp. Madhu Park , Khar (West), Mumbai, Maharashtra, 400052.
Sanguine Novaseeds Private Limited was incorporated on 08 January 2015.
The current directors of Sanguine Novaseeds Private Limited are
The primary industry of Sanguine Novaseeds Private Limited is Professional, Scientific And Technical.
Sanguine Novaseeds Private Limited is unlisted.
The authorized capital of Sanguine Novaseeds Private Limited is ₹10.20 Cr, and the paid-up capital is ₹1.85 Cr.
The compliance status of Sanguine Novaseeds Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX